4/29/2008

The FDA and Physio-Control, a subsidiary of Medtronic, have reached an agreement on a consent decree over external defibrillator quality system improvements. The agreement, which is subject to court approval, includes measures the company must take to resume unrestricted shipment of the devices.

Full Story:
Reuters

Related Summaries